ライフサイエンスコーパス: PKC-zeta

1 hosphorylation sites (Delta1-247/T410E/T560E-PKC-zeta).

2 autoinhibition from the regulatory domain of PKC zeta.

3 m of zeta in the near absence of full-length PKC zeta.

4 rough activation of an atypical PKC isoform, PKC zeta.

5 uggest that MEK is an LPS-directed target of PKC zeta.

6 is both necessary and sufficient to activate PKC zeta.

7 lts demonstrate that FIC1 signals to FXR via PKC zeta.

8 scued by adenovirally mediated expression of PKC-zeta.

9 e similar and differed markedly from that of PKC-zeta.

10 ty, at least in part, via the involvement of PKC-zeta.

11 by overexpression of dominant negative (DN)-PKC-zeta.

12 expression of kinase-inactive RAF, ERK, and PKC-zeta.

13 tes was inhibited by DN-PKC-delta but not DN-PKC-zeta.

14 truncation on insulin-induced activation of PKC-zeta.

15 10E-PKC-zeta, T560E-PKC-zeta, or T410E/T560E-PKC-zeta.

16 0E-PKC-zeta, T560E-PKC-zeta, and T410E/T560E-PKC-zeta.

17 IRS-1 is a novel physiological substrate for PKC-zeta.

18 substrate-1 (IRS-1) as a novel substrate for PKC-zeta.

19 ansphosphorylation by endogenous full-length PKC-zeta.

20 10 phosphorylation in the activation loop of PKC-zeta.

21 ntial for PI3K/PDK-1-dependent activation of PKC-zeta.

22 ve Deltap85 PI3K subunit and kinase-inactive PKC-zeta.

23 nd PKC-zeta, GTPgammaS activated PKN but not PKC-zeta.

24 a nuclear protein as a specific substrate of PKC-zeta.

25 ewise shown to be phosphorylated by purified PKC-zeta.

26 st GLP-1R abolished the effects on PDK-1 and PKC-zeta.

27 A downregulated PKC-alpha and -beta, but not PKC-zeta.

28 tion of PKC-alpha and -beta, but not that of PKC-zeta.

29 ic activity of both PI 3-kinase and atypical PKC-zeta.

30 n (Thr410/403), and nuclear translocation of PKC-zeta.

31 ling proteins are phosphorylation targets of PKC-zeta.

32 her pharmacological or genetic inhibition of PKC-zeta ablated metformin-enhanced phosphorylation of b

33 Finally, inhibition of PKC-zeta abolished metformin-enhanced coimmunoprecipitat

34 PKC zeta activation by AMPK is isoform specific, as smal

35 PKC zeta activation could be useful in therapeutic strat

36 ase (PI 3-kinase), although the mechanism of PKC zeta activation is, as yet, unknown.

37 phosphorylation sites of the PKC betaII nor PKC zeta activation loop-derived peptides were substrate

38 e to phosphorylation of threonine 410 in the PKC zeta activation loop.

39 ylates PKC zeta on residue Thr410 within the PKC zeta activation loop.

40 thway as an integral part of the LPS-induced PKC zeta activation.

41 t not the alpha2 catalytic subunit prevented PKC zeta activation.

42 In this study, we examined the effects of PKC-zeta activation in beta-cell expansion and function

43 However, the effect of direct PKC-zeta activation in the beta-cell in vivo is unknown.

44 PKC-zeta activation is a key signaling event for growth

45 PKC zeta activity was unaffected by its own C1 domain an

46 ignificance for development of modulators of PKC-zeta activity and cellular response to cytokines.

47 AMPK-activating agents stimulate PKC-zeta activity and LKB1 phosphorylation at S307 in en

48 Approaches to enhance PKC-zeta activity may be of value as a therapeutic strat

49 3-kinase activity, Akt phosphorylation, and PKC-zeta activity.

50 Blocking PKC-epsilon, but not PKC-zeta, activity attenuated S1P-mediated PLD stimulati

51 by thrombin, whereas neither PKC epsilon nor PKC zeta affects thrombin-induced PKD activation.

52 However, PKC zeta, an established regulator of cell polarity, was

53 ate of KIF subunits, which is regulated in a PKC zeta and 14-3-3-dependent manner.

54 The association between PKC zeta and PDK-1 reveals extensive cross-talk between

55 vity is modulated by differential effects of PKC zeta and PKA on Raf isoforms.

56 C) signaling pathway, specifically involving PKC zeta and PKC delta isoforms.

57 Moreover, CsA promoted the association of PKC zeta and PKC delta with the transcription factor Sp1

58 necessary for ceramide-induced activation of PKC zeta and resultant diminished Akt activity, leading

59 PDK1 was able to phosphorylate full-length PKC-zeta and -delta but not PKC-zeta and -delta construc

60 late full-length PKC-zeta and -delta but not PKC-zeta and -delta constructs containing the PDK1 phosp

61 The ability of PDK1 to phosphorylate PKC-zeta and -delta in vitro was also markedly inhibited

62 al tail of PKC is a critical determinant for PKC-zeta and -delta phosphorylation by PDK1.

63 PDK1 with the PKCs required the full-length PKC-zeta and -delta proteins apart from their C-terminal

64 phorylation and PDK1 kinase activity against PKC-zeta and -delta.

65 a/beta1 act upstream of JNKs, not ERK1/2; 3) PKC-zeta and -theta, not PKC-epsilon, act upstream of JN

66 for PKC-zeta inhibited the translocation of PKC-zeta and 70% of the carbachol-stimulated insulin sec

67 t of PC12 cells resulted in translocation of PKC-zeta and coincident phosphorylation of a protein tha

68 phosphorylation of activation loop sites in PKC-zeta and lambda, and subsequent autophosphorylation

69 by co-expression of kinase-inactive forms of PKC-zeta and PKC-lambda but not by a double mutant (T308

70 truncated, pseudosubstrate-lacking forms of PKC-zeta and PKC-lambda by a wortmannin-sensitive mechan

71 branes and microsomes and (b) immunoreactive PKC-zeta and PKC-lambda in GLUT4 vesicles.

72 findings suggest that insulin activates both PKC-zeta and PKC-lambda in plasma membranes, microsomes,

73 ylation of immunoprecipitable epitope-tagged PKC-zeta and PKC-lambda were also increased by insulin i

74 memory, we generated transgenic mice lacking PKC-zeta and PKM-zeta.

75 ively active AMPK was sufficient to activate PKC-zeta and promote Na,K-ATPase endocytosis.

76 d for phosphorylation of activation loops of PKC-zeta and protein kinase B, we compared their activat

77 ng in vitro autophosphorylation of wild-type PKC-zeta and T410E-PKC-zeta, insulin and PIP(3) did not

78 02 abrogated the IGF-I-induced activation of PKC-zeta and totally blocked the enhancement in macropha

79 ed with phosphorylation of protein kinase C (PKC zeta) and extracellular signal-regulator kinase (ERK

80 In this study phosphorylated PKC zeta (p-PKC zeta) and Glycogen Synthase Kinase 3beta (GSK3 beta)

81 e mice that lack both protein kinase C-zeta (PKC-zeta) and PKM-zeta (Prkcz(-/-) mice).

82 wnstream kinase, e.g. protein kinase C-zeta (PKC-zeta) and/or protein kinase N (PKN).

83 LPS also activated PKC zeta, and this activation was inhibited by D609.

84 eraction, inhibited ROS production, degraded PKC-zeta, and activated caspases-3 and -8 to block trans

85 overexpression of ERK, PKC-alpha, PKC-delta, PKC-zeta, and Akt; and dominant negative (DN) mutants of

86 -zeta, T410E/T560A-PKC-zeta, and T410A/T560E-PKC-zeta, and largely intact in T410E-PKC-zeta, T560E-PK

87 nt protein kinase C (PKC) isoform designated PKC-zeta, and overexpression of this enzyme leads to mon

88 y compromised in T560A-PKC-zeta, T410E/T560A-PKC-zeta, and T410A/T560E-PKC-zeta, and largely intact i

89 and largely intact in T410E-PKC-zeta, T560E-PKC-zeta, and T410E/T560E-PKC-zeta.

90 s IRS-1 coimmunoprecipitated with endogenous PKC-zeta, and this association was increased 2-fold upon

91 In AEC treated with a PKC-zeta antagonist peptide or with the Na,K-ATPase alph

92 activate the kinase function of full-length PKC zeta, apparently by inducing a conformational change

93 ) that protein kinase C (PKC)-a and atypical PKC-zeta are the two major PKC isozymes in the normal ep

94 n this study, we have sought to identify the PKC-zeta associated kinase and understand how PKC-zeta m

95 The in vivo PKC-zeta-associated CK2 preferentially phosphorylates S2

96 We demonstrate that the PKC-zeta-associated IkappaBalpha kinase is CK2.

97 d close association of these proteins with p-PKC zeta at the meiotic spindle.

98 orm, which binds and directly phosphorylates PKC zeta at Thr410, thereby promoting Na,K-ATPase endocy

99 inhibitors or overexpression of kinase-dead PKC-zeta attenuated Sp1 phosphorylation and ABCA1 expres

100 Presently, we show that hBVR increases PKC-zeta autophosphorylation, stimulation by TNF-alpha,

101 alpha was necessary for hypoxia-induced AMPK-PKC zeta binding in alveolar epithelial cells.

102 -zeta (PKC-zeta) phosphorylation and induced PKC-zeta binding with Sp1.

103 PKC zeta binds and phosphorylates the zinc finger region

104 of RelA at Ser311 by protein kinase C-zeta (PKC-zeta) blocked the binding of GLP to RelAK310me1 and

105 f PKC-zeta, VEGF expression was dependent on PKC-zeta but not Akt.

106 andem VCAM-1 GATA motifs was inhibited by DN-PKC-zeta but not DN-PKC-delta.

107 Ile/Leu at the P-1 position is disfavored by PKC-zeta but not PKC-delta.

108 T560A-PKC-zeta, T410E/T560A, and T410A/T560E-PKC-zeta but not T410E-PKC-zeta, T560E-PKC-zeta, or T410

109 Under in vitro conditions, wild-type PKC-zeta (but not kinase-deficient mutant PKC-zeta) sign

110 Knockdown of PKC zeta, but not PKC iota/lambda, expression using spec

111 d threonine 560 autophosphorylation sites in PKC-zeta, but had no effect on PI 3-kinase activation or

112 Likewise, addition of purified PKC-zeta, but neither PKC-alpha nor delta, to nuclear ex

113 Accordingly, in L6 myotubes, RNAi-targeting PKC-zeta, but not PKC-lambda, markedly depleted aPKC and

114 ed by >90% the phosphorylation of endogenous PKC-zeta by PDK1.

115 Activation of protein kinase C-zeta (PKC-zeta) by insulin requires phosphatidylinositol (PI)

116 raction, peptide #2 disrupts function of the PKC-zeta C1 domain, and peptide #3 alters ATP presentati

117 ions for Thr(410) of the catalytic domain of PKC zeta (CAT zeta) essentially abolished the kinase fun

118 synthesized from a PKM zeta mRNA encoding a PKC zeta catalytic domain without a regulatory domain.

119 zeta (PKC-zeta) since specific inhibition of PKC-zeta caused an aggregation of endoglin or TbetaRII o

120 adenovirus-mediated delivery of kinase-dead PKC zeta completely inhibited beta-cell proliferation in

121 Interestingly, the PKC-zeta consensus sequence surrounding LKB1 S307 is dis

122 Arachidonic acid restores activation of PKC-zeta, correcting the exaggerated IGF-1 signaling.

123 -1 promoter in vivo and that this binding is PKC zeta dependent.

124 esulted in abrogation of ceramide-activated, PKC zeta-dependent Akt inactivation, whereas molecular s

125 several physiological stimuli converge upon PKC-zeta-dependent LKB1 phosphorylation at S307, which d

126 tion by statin is peroxynitrite-mediated but PKC-zeta-dependent.

127 In addition, PKC-zeta did not mediate stretch-induced ERK1/2 activati

128 Recombinant PKC zeta directly phosphorylated immunoprecipitated FXR.

129 We suggest peptide #1 blocks PKC-zeta-docking site interaction, peptide #2 disrupts f

130 Consistently, inhibition of PKC-zeta either by pharmacological or genetic manipulati

131 on of pp106, by comparison overexpression of PKC-zeta enhanced basal phosphorylation without a notice

132 t insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T41

133 ide 3-kinase (PI3-K), protein kinase C-zeta (PKC-zeta), extracellular signal-regulated kinase 1/2 (ER

134 eta-stimulated increases in translocation of PKC-zeta from cytosolic to membrane fractions.

135 ordinate activity of PKC-delta-NF-kappaB and PKC-zeta-GATA signaling pathways.

136 Whereas insulin activated both PKN and PKC-zeta, GTPgammaS activated PKN but not PKC-zeta.

137 PKC zeta has been shown in other systems to be phosphory

138 PKC zeta has received considerable attention recently as

139 PKC-zeta has been shown to be associated with an IkappaB

140 ker rats were injected with adenoviral/human PKC-zeta (hPKC-zeta) and adenoviral/LacZ in opposing tib

141 In vitro, PDK-1 phosphorylates and activates PKC zeta in a Ptdins-3,4,5-P3-enhanced manner.

142 Inhibition of PKC zeta in Caco-2 cells resulted in activation of the h

143 s-mediated delivery of constitutively active PKC zeta in mouse and human primary islet cells signific

144 the kinase that phosphorylates and activates PKC zeta in the PI 3-kinase signaling pathway.

145 PDK-1 phosphorylates and activates PKC zeta in vivo, and we have shown that this is due to

146 TNF-alpha did not stimulate PKC-zeta in cells infected with small interfering RNA fo

147 PKC-zeta in L6 myotubes and PKC-lambda in 3T3/L1 adipocy

148 In addition, the overexpression of PKC-zeta in NIH-3T3(IR) cells caused significant phospho

149 Furthermore, the overexpression of PKC-zeta in NIH-3T3(IR) cells significantly impaired ins

150 n of IkappaB molecules, co-precipitates with PKC-zeta in resting cells.

151 ic (TG) mice with constitutive activation of PKC-zeta in the beta-cell.

152 sphorylation of PKC (alpha, beta, delta) and PKC-zeta in the cytosol of C5(-/-) macrophages compared

153 al muscle in vivo and also affirm a role for PKC-zeta in the regulation of glucose transport activity

154 a, thus approximately doubling the amount of PKC-zeta in tibialis anterior.

155 e-1 (PDK-1), AKT, and protein kinase C zeta (PKC-zeta) in HepG2 and Huh7 cells.

156 the atypical protein kinase C (PKC) isoform, PKC zeta, in LPS-induced activation of the ERK kinase pa

157 n of threonine 410 in the activation loop of PKC-zeta; in contrast, protein kinase B (PKB) activation

158 fying mTOR as a novel downstream mediator of PKC-zeta-induced beta-cell replication and expansion in

159 ivation, whereas inhibition of PKC-theta and PKC-zeta inhibited IL-1beta-stimulated activation of NF-

160 Expression of dominant-negative PKC-zeta inhibited NGF-induced phosphorylation of pp106,

161 eudosubstrate peptide inhibitor specific for PKC-zeta inhibited the translocation of PKC-zeta and 70%

162 A protein kinase C-zeta (PKC-zeta) inhibitor (a pseudosubstrate oligopeptide), bu

163 could be blocked with protein kinase C zeta (PKC zeta) inhibitors (pseudosubstrate or small interferi

164 sphorylation of wild-type PKC-zeta and T410E-PKC-zeta, insulin and PIP(3) did not stimulate autophosp

165 In vitro, PKC-zeta interacts with CK2-beta.

166 at the plasma membrane, a membrane-targeted PKC zeta is constitutively active in the absence of agon

167 PKC zeta is essential for PTHrP- and HGF-induced beta-ce

168 ndings indicate that the catalytic domain of PKC zeta is intrinsically inactive and dependent on the

169 Because PKC-zeta is located downstream from IRS-1 and phosphatid

170 Protein kinase C zeta (PKC zeta) is a member of the PKC family of enzymes and i

171 s in mammalian cells, protein kinase C zeta (PKC zeta) is processed between the regulatory and cataly

172 Protein kinase C-zeta (PKC-zeta) is a serine/threonine kinase downstream from p

173 independent catalytic domain of the atypical PKC zeta isoform and produces long term effects at synap

174 ion of PKC-beta1 and -delta isoforms but not PKC-zeta isoform by adenovirus vectors containing the re

175 and specifically with protein kinase C zeta (PKC zeta) isoform in renal cell carcinoma.

176 PKC alpha, but not PKC epsilon, PKC delta or PKC zeta isoforms, increased Ro3582-induced phosphorylat

177 ticularly nuclear PKC-alpha and the atypical PKC-zeta isozymes.

178 As expected, downstream signaling events of PKC-zeta (JNK phosphorylation and NF-kappaBeta accumulat

179 was similar to the response of "kinase-dead" PKC-zeta(K281R).

180 A PKC zeta knockout mouse, in which the regulatory domain

181 p-MARCKS and the active form of the atypical PKC zeta/lambda isoform(s) were very similar.

182 This defect in insulin-induced PKC-zeta/lambda activation was associated with diminishe

183 cts of okadaic acid on glucose transport and PKC-zeta/lambda activity, okadaic acid provoked insulin-

184 Insulin effects on PKC-zeta/lambda and 2-deoxyglucose uptake were diminishe

185 operation of a novel pathway for activating PKC-zeta/lambda and glucose transport.

186 nduced activation and autophosphorylation of PKC-zeta/lambda but did not inhibit PDK-1-dependent (a)

187 reases in the activity of immunoprecipitable PKC-zeta/lambda by a PI 3-kinase-dependent mechanism.

188 in insulin-stimulated 2-deoxyglucose uptake, PKC-zeta/lambda enzyme activity and phosphorylation of b

189 tly, we found that glucose acutely activated PKC-zeta/lambda in rat adipocytes and rat skeletal muscl

190 to diminished phosphorylation/activation of PKC-zeta/lambda, and (b) thiazolidinediones enhance gluc

191 This activation of PKC-zeta/lambda, moreover, appeared to be required for g

192 s in phosphatidic acid, a known activator of PKC-zeta/lambda.

193 h increases in phosphorylation/activation of PKC-zeta/lambda.

194 ly, like renal cancer cells, in AsPC-1 cells PKC-zeta leads to direct Sp1-dependent VPF/VEGF transcri

195 irectly activate aPKCs; additionally, muscle PKC-zeta levels were diminished by 40%.

196 The mechanism by which p-PKC zeta maintains spindle organization appears to be th

197 NAi constructs targeting PKC-lambda, but not PKC-zeta, markedly depleted aPKC and concomitantly inhib

198 to, increases in glucose transport; and (c) PKC-zeta may contribute to increases in glucose transpor

199 sults suggest that the presence of Arg-20 in PKC-zeta may contribute to its lack of phorbol ester bin

200 e in established insulin signaling pathways, PKC-zeta may participate in negative feedback pathways t

201 nstrate that the association between CK2 and PKC-zeta may play a major role in the control of the bas

202 -alpha and PKC-epsilon, but not PKC-delta or PKC-zeta, mediate SRE activation.

203 TPase endocytosis via protein kinase C zeta (PKC zeta)-mediated phosphorylation of the Na,K-ATPase al

204 ts endocytosis through mitochondrial ROS and PKC-zeta-mediated phosphorylation of the Na,K-ATPase alp

205 KC-zeta associated kinase and understand how PKC-zeta mediates basal IkappaBalpha turnover in vivo.

206 8 entry into the target cells and a role for PKC-zeta, MEK, and ERK at a post-viral entry stage of in

207 Inhibitors specific for PI 3-kinase, PKC-zeta, MEK, and ERK significantly reduced the virus i

208 AMPK-Thr172 and LKB1-Ser428, suggesting that PKC-zeta might act as an upstream kinase for LKB1.

209 se activity assays showed that LPS activates PKC zeta, mitogen-activated protein/ERK kinase (MEK, the

210 on of brain PKM zeta does not correlate with PKC zeta mRNA but instead with an alternate zeta RNA tra

211 n 11-base region of complementarity with the PKC-zeta mRNA, wheras Isis 3522 has only a 4-base region

212 amide and a truncated, constitutively active PKC-zeta mutant lacking all regulatory domain elements a

213 ated and stimulated autophosphorylation of a PKC-zeta mutant, in which threonine 410 is replaced by g

214 oligonucleotides and antisense PKC-alpha and PKC-zeta oligonucleotides had no effect on ERK1/2 activi

215 We found that AMPK alpha phosphorylates PKC zeta on residue Thr410 within the PKC zeta activatio

216 9 cells transfected with a dominant negative PKC zeta, or expressing the K18Ser33Ala mutation, is unc

217 T560E-PKC-zeta but not T410E-PKC-zeta, T560E-PKC-zeta, or T410E/T560E-PKC-zeta.

218 In this study phosphorylated PKC zeta (p-PKC zeta) and Glycogen Synthase Kinase 3beta

219 Phosphorylated PKC zeta (p-PKC zeta) was immunopurified from MII eggs a

220 We found that a peptide specific for PKC zeta partially blocked activation of both MEK and ER

221 activity were completely abolished in T410A-PKC-zeta, partially compromised in T560A-PKC-zeta, T410E

222 dnPKC-zeta, or treatment with myristoylated PKC-zeta peptide inhibitor abrogated S1P-induced Rac1 ac

223 kinase C (PKC)-delta inhibitor, rottlerin, a PKC-zeta peptide inhibitor, or by overexpression of domi

224 GATA motif was inhibited by LY294002 and the PKC-zeta peptide inhibitor.

225 LPS-activated PKC zeta phosphorylated MAP kinase kinase, the kinase di

226 to be through GSK3 beta and suggests that p-PKC zeta phosphorylates GSK3 beta on the ser9 position i

227 PKC zeta phosphorylates K18pSer33, and this is required

228 In a cell-free system, recombinant PKC-zeta phosphorylates LKB1 at S307.

229 We conclude that PKC-zeta phosphorylates LKB1 at Ser428, resulting in LKB

230 r strategies suggest that ceramide-dependent PKC zeta phosphorylation of Akt3 at Ser(34) was necessar

231 ase protein kinase C (PKC)-zeta activity and PKC-zeta phosphorylation at Thr(410)/Thr(403).

232 eatment also elevated protein kinase C-zeta (PKC-zeta) phosphorylation and induced PKC-zeta binding w

233 es PI 3-kinase and causes the formation of a PKC zeta/PI 3-kinase-dependent kinase complex.

234 PKC-zeta, PKC-delta, and PRK2 were identified as interac

235 We demonstrate that the atypical isoform PKC zeta (PKCzeta) has a role in insulin-stimulated curr

236 find that both conventional and conditional PKC-zeta/PKM-zeta knockout mice show normal synaptic tra

237 Notably, ZIP still reverses LTP in PKC-zeta/PKM-zeta knockout mice, indicating that the eff

238 Protein kinase C-zeta (PKC-zeta) plays a central role in VPF/VEGF expression an

239 The overexpression of T410A mutant PKC zeta prevented hypoxia-induced Na,K-ATPase endocytos

240 a 4-base region, the effect of Isis 3521 on PKC-zeta protein and mRNA expression may be due to irrel

241 fected by this treatment, but elimination of PKC-zeta protein and mRNA were observed.

242 a, indicating that this form of PKM is not a PKC zeta proteolytic fragment.

243 Both RO 31-8220 and myristoylated PKC-zeta pseudosubstrate blocked insulin-induced activat

244 Inhibition of PKC-zeta using PKC-zeta pseudosubstrate inhibited IL-1beta-stimulated i

245 c zeta inhibitory peptide (ZIP) based on the PKC-zeta pseudosubstrate sequence reverses established L

246 126, 1-butanol, cell-permeable myristoylated PKC-zeta pseudosubstrate, and expression of kinase-inact

247 tivate PKC-epsilon and, subsequently, a PLD2-PKC-zeta-Rac1 cascade.

248 ; and dominant negative (DN) mutants of ERK, PKC-zeta, Ras, PI 3-kinase and Akt.

249 In addition, overexpression of PKC-zeta resulted in a strong constitutive up-regulation

250 Moreover, overexpressing PKC-zeta results in lower steady-state protein levels of

251 findings therefore suggested that PDK-1 and PKC-zeta serve as a downstream effectors of PI3K, and ac

252 pe PKC-zeta (but not kinase-deficient mutant PKC-zeta) significantly phosphorylated IRS-1.

253 ffect was mediated by protein kinase C-zeta (PKC-zeta) since specific inhibition of PKC-zeta caused a

254 Similarly, in vivo transfection of PKC-zeta-specific small interfering RNA in C57BL/6J mice

255 y inhibitors of protein kinase C (PKC) or of PKC-zeta, specifically.

256 or C-->A derivatives, respectively, blocked PKC-zeta stimulation by TNF-alpha and its membrane trans

257 inal-based peptide KYCCSRK296 (#3), enhanced PKC-zeta stimulation by TNF-alpha; for this, Lys296 was

258 mised by expression of T410A-PKC-zeta, T560A-PKC-zeta, T410E/T560A, and T410A/T560E-PKC-zeta but not

259 10A-PKC-zeta, partially compromised in T560A-PKC-zeta, T410E/T560A-PKC-zeta, and T410A/T560E-PKC-zeta

260 tion were compromised by expression of T410A-PKC-zeta, T560A-PKC-zeta, T410E/T560A, and T410A/T560E-P

261 /T560E-PKC-zeta, and largely intact in T410E-PKC-zeta, T560E-PKC-zeta, and T410E/T560E-PKC-zeta.

262 560A, and T410A/T560E-PKC-zeta but not T410E-PKC-zeta, T560E-PKC-zeta, or T410E/T560E-PKC-zeta.

263 dent upon PI 3-kinase-mediated activation of PKC-zeta that is independent of stretch-induced activati

264 Surprisingly, insulin activated a truncated PKC-zeta that lacks the regulatory (presumably PIP(3)-bi

265 However, specific substrates for PKC-zeta that participate in the biological actions of i

266 analyze the interaction between ceramide and PKC zeta, the ability of ceramide to localize within hig

267 ced Na,K-ATPase endocytosis, confirming that PKC zeta Thr410 phosphorylation is essential for this pr

268 e uptake, PKCzeta/lambda enzyme activity and PKC-zeta threonine 410 phosphorylation, but had no effec

269 of the level (fast-twitch red) of endogenous PKC-zeta, thus approximately doubling the amount of PKC-

270 T410E/T560A, or T410E/T560E mutant forms of PKC-zeta; thus, T560 appeared to be the sole autophospho

271 abeled HEK293 cells transfected with hBVR or PKC-zeta, TNF-alpha increased hBVR phosphorylation.

272 In addition, we found that LPS caused PKC zeta to bind to MEK in vivo.

273 ts of PKC-alpha, PKC-delta, PKC-epsilon, and PKC-zeta to determine the roles of individual isoforms o

274 and modulated by a negative feedback loop of PKC-zeta to IRS-2.

275 Thus ROS and the PKC-zeta to p47(phox) interaction are valid therapeutic

276 Here we demonstrate that a novel PKC-zeta to p47(phox) interaction is required for ROS pr

277 ibitor BI-D1870 with TNF-alpha inhibited the PKC-zeta to p47(phox) interaction, inhibited ROS product

278 nd directly activated protein kinase C zeta (PKC zeta) to suppress Akt-dependent mitogenesis.

279 Hypoxia-induced PKC zeta translocation to the plasma membrane and phosph

280 VR and PKC betaII, but not the reductase and PKC zeta, transphosphorylated in assay systems supportiv

281 Inhibition of PKC-zeta using PKC-zeta pseudosubstrate inhibited IL-1be

282 Inhibition of PKC-theta and PKC-zeta using pseudosubstrates inhibited IL-1beta-stimu

283 sed both Akt phosphorylation and activity of PKC-zeta, VEGF expression was dependent on PKC-zeta but

284 ured lipid microdomains (rafts) and activate PKC zeta was investigated.

285 d novel isoforms were decreased and atypical PKC-zeta was elevated.

286 This was a specific effect, as nontargeted PKC-zeta was not changed by PKC-delta siRNA oligonucleot

287 Phosphorylated PKC zeta (p-PKC zeta) was immunopurified from MII eggs and was found

288 ion, demonstrating that PKC-epsilon, but not PKC-zeta, was upstream of PLD.

289 ddition to requirements for PI3K, PDK-1, and PKC-zeta, we found that a tyrosine kinase (presumably th

290 were increased, whereas PKC-eta and atypical PKC-zeta were decreased.

291 Furthermore, the levels of phospho-PKC-zeta were lower in the cytosolic fractions of OPN kn

292 ng of phagosomes indicated that PKC-beta and PKC-zeta were the isoforms that are not phosphorylated i

293 ase (PI 3-kinase) and protein kinase C-zeta (PKC-zeta) were recruited as upstream mediators of the HH

294 ts are uniquely controlled by PI3 kinase and PKC-zeta, which act upstream of Aurora A.

295 utation of Thr-410 in the activation loop of PKC-zeta, which is the target of PDK-1 and is essential

296 mide specifically reduced the association of PKC zeta with 14-3-3, a scaffold protein localized to le

297 Inhibition of PKC-zeta with kinase inhibitors or overexpression of kin

298 rambled ZIP inhibited PKM-zeta, PKC-iota and PKC-zeta with similar inhibition constant (K(i)) values.

299 ncreased localization and phosphorylation of PKC zeta within caveolin-enriched lipid microdomians to

300 Lastly, it is shown that PKC-zeta wt but not kinase dead leads to the in vitro ph